Viewing nowAmorin Tablet (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Bionex Co., Ltd.

MFDS item code 200400570 · Notified 2004.06.24 · Insurance code 643101360
Improvement of blood sugar control in type 2 diabetes
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, or in some cases, in combination with other oral hypoglycemics or insulin. Particularly, when blood sugar control is difficult with sulfonylureas or metformin monotherapy, it can be used with metformin. This helps to improve blood sugar control and enables more effective diabetes management.
For patients who have not previously been treated with medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 to 2 weeks. Generally, there is little additional effect when doses exceed 4 mg, but some patients may be able to increase to 6 mg (or 8 mg). If 4 mg daily fails, consider insulin therapy.
This drug should not be used in patients with type 1 diabetes or those suffering from diabetic ketoacidosis or coma. Those who have had allergic reactions to this drug, its components, or sulfonylureas should not take it. In patients with severe liver or kidney impairment, it is advisable to switch to insulin treatment instead of using this drug. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication. In patients with severe infections, post-surgery, or severe trauma, insulin therapy is recommended. Patients with gastrointestinal disorders such as diarrhea or vomiting should be cautious as the risk of hypoglycemia increases with this drug. This drug contains lactose, so individuals with lactose deficiency or galactose intolerance should not take it. During the first week of treatment, there is a high risk of hypoglycemia, so blood sugar levels should be monitored frequently and carefully observed. Elderly patients, those with poor nutritional status, irregular eating patterns, excessive alcohol intake, and reduced liver or kidney function are at a higher risk for hypoglycemia. Caution is also needed in patients with other endocrine disorders or those who have overdosed on medications. Those with an allergy to Yellow No. 4 (Tartrazine) should use this drug with caution. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, decreased consciousness, etc., and immediate treatment is required if these symptoms occur. Blurred vision or gastrointestinal disturbances, and in rare cases, liver dysfunction or blood abnormalities may also occur, so the physician should be informed if abnormal symptoms develop. While taking this medication, regular meals and exercise are important, and blood sugar control should be continuously monitored. In the event of hypoglycemia, quickly consuming sugar is necessary to alleviate symptoms, as non-sweeteners containing no sugar are ineffective. When taking this drug with others, inform your doctor or pharmacist about any medications you are currently taking, as interactions may affect blood sugar control. If pregnant or breastfeeding, consult a physician as it may be harmful to the fetus or newborn. In the case of overdose, severe hypoglycemia may occur, and you should seek medical attention promptly for appropriate treatment. Safety and efficacy in children have not been established, and elderly patients may require dosage adjustments due to decreased kidney function. Store this drug out of reach of children and keep it tightly closed in its original container.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, yellowing of the skin or eyes (jaundice), extreme lethargy accompanied by rising blood pressure, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, markedly reduced urine output, thrombocytopenia, leukopenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid contact with air or moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.
Green elongated tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Bionex Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.